UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule
14a-101)
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the
Registrant ☒ Filed by a Party other than the
Registrant ☐
Check the appropriate box:
|
|
|
☐
|
|
Preliminary Proxy Statement
|
|
|
☐
|
|
Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
☐
|
|
Definitive Proxy Statement
|
|
|
☒
|
|
Definitive Additional Materials
|
|
|
☐
|
|
Soliciting Material Pursuant to
§240.14a-12
|
GNC HOLDINGS, INC.
(Name
of Registrant as Specified in Its Charter)
(Name of Person(s)
Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
|
|
|
|
|
|
☒
|
|
No fee required.
|
|
|
☐
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
|
|
|
(1)
|
|
Title of each class of securities to which transaction applies:
|
|
|
(2)
|
|
Aggregate number of securities to which transaction applies:
|
|
|
(3)
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing
fee is calculated and state how it was determined):
|
|
|
(4)
|
|
Proposed maximum aggregate value of transaction:
|
|
|
(5)
|
|
Total fee paid:
|
|
|
☐
|
|
Fee paid previously with preliminary materials:
|
|
|
☐
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the form or schedule and the date of its filing.
|
|
|
|
|
|
(1)
|
|
Amount previously paid:
|
|
|
(2)
|
|
Form, Schedule or Registration Statement No.:
|
|
|
(3)
|
|
Filing Party:
|
|
|
(4)
|
|
Date Filed:
|
GNC ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS UNTIL
10:00 AM EASTERN TIME ON MAY 17, 2018
Votes Received to Date Indicate Strong Support for Share Issuance in
Connection with Hayao Investment
Shareholders Who Have Not Yet Voted are Encouraged to Vote During Adjournment Every Vote Counts
PITTSBURGH, May 9, 2018 GNC Holdings, Inc. (NYSE: GNC) (the Company) today announced that its Special Meeting of
Stockholders, scheduled for and convened on April 25, 2018 and to be reconvened on May 9, 2018 (the Special Meeting), will be further adjourned until 10:00 A.M., Eastern Time, on May 17, 2018 at the Omni William Penn, 530
William Penn Place, Sternwheeler Room, Pittsburgh, Pennsylvania 15219 to allow additional time to solicit proxies and obtain a quorum for the meeting.
The Company noted that while a substantial majority (over 93%) of the proxies received as of May 8, 2018 authorized a vote in favor of the
issuance of convertible preferred shares to Harbin Pharmaceutical Group Holdings Co., Ltd. (Hayao) (the Share Issuance Proposal) in connection with Hayaos strategic investment in the Company, holders of approximately
45% of the outstanding shares of the Companys common stock had submitted proxies to vote at the Special Meeting. Approval of the Share Issuance Proposal requires the affirmative vote of a majority of the shares present (in person or by proxy)
and entitled to vote at the Special Meeting. However, although the number of outstanding shares of the Companys common stock that have submitted proxies to vote at the Special Meeting has increased significantly from the 36% that had been
submitted as of April 25, 2018, which was the original date for the Special Meeting, the necessary quorum of a majority of the outstanding shares of the Companys common stock still has not been established for the Special Meeting. In
addition to noting the initial indication of shareholder support, GNC also noted that leading proxy advisory firms, Institutional Shareholder Services Inc. and Glass, Lewis & Co., recommend shareholders vote FOR the Share
Issuance Proposal.
During the adjournment period, the Company will continue to solicit proxies from its stockholders with respect to the
Share Issuance Proposal. Only stockholders of record on the record date of March 23, 2018 (the Record Date), are entitled to and are being requested to vote. If a stockholder has previously submitted its proxy card and does not wish
to change its vote, no further action is required by such stockholder.
The Share Issuance Proposal is described in further detail in the
proxy statement filed with the Securities and Exchange Commission (SEC) on March 26, 2018 and mailed to stockholders on or about March 26, 2018. No changes have been made in the proposal to be voted on by stockholders at the
Special Meeting. The Companys proxy statement and any other materials filed by the Company with the SEC remain unchanged and can be obtained free of charge at the SECs website at
www.sec.gov
.
GNC encourages all stockholders that have not yet voted to vote their shares by 11:59 p.m.,
Eastern Time, on Wednesday, May 16, 2018. If you have not voted, or have misplaced your proxy materials or are uncertain if you have voted all the shares you are entitled to vote please see How You Can Vote, below. Every single vote
counts.
How You Can Vote
If
you have any questions about how to vote, please contact MacKenzie Partners, Inc. at (800)
322-2885
or via email at proxy@mackenziepartners.com.
Stockholders of Record
The
deadline for voting online is 11:59 pm EST on Wednesday, May 16, 2018. The Company encourages record holders to vote in one of the following ways:
|
1.
|
Internet
. Go to www.proxyvote.com to use the Internet to transmit your voting instructions. Have your
proxy card in hand when you access the website. The new deadline for voting online is 11:59 pm EST on Wednesday, May 16, 2018.
|
|
2.
|
Phone
. Call
1-800-690-6903
using any touch-tone telephone to transmit your voting instructions. Have your proxy card in hand when you call.
|
Voting by any of these methods will not affect your right to attend the Special Meeting and vote in person. However, for those who will not be
voting in person at the Special Meeting, your final voting instructions must be received by no later than 11:59 p.m., Eastern Time, on May 16, 2018.
All stockholders of record as of the Record Date may attend the Special Meeting and vote in person. Stockholders will need to present proof of
ownership of our Common Stock as of the Record Date, such as a bank or brokerage account statement, and a form of personal identification to be admitted to the Special Meeting. No cameras, recording equipment, electronic devices, large bags,
briefcases or packages will be permitted in the Special Meeting.
Beneficial Owners
Most of our stockholders hold their shares through a broker, bank or other nominee, rather than directly in their own name. If you hold your
shares in one of these ways, you are considered the beneficial owner of shares held in street name, and the proxy materials were forwarded to you by your broker, bank or nominee, who is considered, with respect to those shares, the stockholder of
record. As the beneficial owner, you have the right to direct your broker, bank or nominee on how to vote. Your broker, bank or nominee enclosed a voting instruction form for you to use in directing the broker, bank or nominee on how to vote your
shares. If you hold your shares through an NYSE member brokerage firm, that member brokerage firm does not have the discretion to vote shares it holds on your behalf without instructions from you with respect to the Share Issuance Proposal.
The Board of Directors of the Company recommends that the Companys stockholders vote
FOR the Share Issuance Proposal.
About Us
GNC Holdings, Inc. (NYSE: GNC) - Headquartered in Pittsburgh, PA - is a leading global specialty health, wellness and performance retailer.
GNC connects customers to their best selves by offering a premium assortment of heath, wellness and performance products, including
protein, performance supplements, weight management supplements, vitamins, herbs and greens, wellness supplements, health and beauty, food and drink and other general merchandise. This assortment features proprietary GNC and nationally recognized
third-party brands.
GNCs diversified, multi-channel business model generates revenue from product sales through company-owned
retail stores, domestic and international franchise activities, third-party contract manufacturing,
e-commerce
and corporate partnerships. As of March 31, 2018, GNC had approximately 8,900 locations, of
which approximately 6,700 retail locations are in the United States (including approximately 2,400 Rite Aid franchise
store-within-a-store
locations) and franchise
operations in approximately 50 countries.
About Harbin Pharmaceutical Group Holding Co., Ltd.
Harbin Pharmaceutical Group Holding Co., Ltd. Headquartered in Harbin City Heilongjiang Province, China is one of the leading
pharma and VMS companies in China. Hayao has a broad portfolio of OTC
(Over-The-Counter),
Rx (prescription) and VMS products, and is also engaged in pharma distribution
and retail pharmacy businesses. Hayao has many National renowned brands that have very high consumer awareness including San Jing, and command leading market share in the mineral supplements category.
Hayao has access to an extensive distribution and retailing network by directly operating more than 300 chain retail pharmacies and
collaboration with around 800 drug and VMS distributors to build Nation-wide coverage.
Additional Information About the Equity Issuance and Where
to Find It
In connection with the proposed equity issuance, on March 26, 2018, GNC filed with the SEC and sent to its
stockholders a definitive proxy statement. INVESTORS OF GNC ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT AND OTHER RELEVANT MATERIALS CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT GNC, HAYAO AND THE
PROPOSED EQUITY ISSUANCE. Investors may obtain a free copy of these materials and other documents filed by GNC with the SEC at the SECs website at www.sec.gov, at GNCs website at www.gnc.com or by sending a written request to GNC at GNC
Holdings, Inc., 300 Sixth Avenue, Pittsburgh, Pennsylvania 15222, Attention: Secretary.
Forward-Looking Statements
This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with
respect to the Companys financial condition, results of operations and business that is not historical information. Forward-looking statements can be identified by the use of terminology such as subject to, believes,
anticipates, plans, expects, intends, estimates, projects, may, will, should, can, the negatives thereof, variations thereon and
similar expressions, or by discussions regarding dividend, share repurchase plan, strategy and outlook. While GNC believes there is a reasonable basis for its expectations and beliefs, they are inherently uncertain. The Company may not realize its
expectations and its beliefs may not prove correct. Many factors could affect future performance and cause actual results to differ materially from those matters expressed in or implied by forward-looking statements, including but not limited to
(1) GNC may be unable to obtain stockholder approval as required for the equity issuance; (2) conditions to the closing of the transaction may not be satisfied and required regulatory approvals may not be obtained; (3) the transaction
may involve unexpected costs, liabilities or delays; (4) the business of GNC may suffer as a result of uncertainty surrounding the transaction; (5) the outcome of any legal proceedings related to the transaction; (6) GNC may be
adversely affected by other economic, business, legislative, regulatory and/or competitive factors; (7) the occurrence of any event, change or other circumstances that could give rise to the termination of the securities purchase agreement; or
(8) other risks to consummation of the transaction, including the risk that the transaction will not be consummated within the expected time period or at all. The Company undertakes no obligation to publicly update or revise any forward-looking
statement, whether as a result of new information, future events or otherwise. Actual results could differ materially from those described or implied by such forward-looking statements. For a listing of factors that may materially affect such
forward-looking statements, please refer to the Companys Annual Report on Form
10-K
for the year ended December 31, 2017.
This document will not constitute an offer to sell or the solicitation of an offer to buy any securities, nor will there be any sale of
securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.
Participants in Solicitation
The
Company and its directors, executive officers and certain other members of management and employees may be deemed to be participants in soliciting proxies from its stockholders in connection with the proposed equity issuance. Information regarding
the persons who may, under the rules of the SEC, be considered to be participants in the solicitation of the Companys stockholders in connection with the proposed equity issuance are set forth in the Companys definitive proxy statement
for its special stockholder meeting. Additional information regarding these individuals and any direct or indirect interests they may have in the proposed equity issuance are set forth in the definitive proxy statement filed on March 26, 2018
with the SEC in connection with the proposed equity issuance.
GNC (NYSE:GNC)
Historical Stock Chart
From Mar 2024 to Apr 2024
GNC (NYSE:GNC)
Historical Stock Chart
From Apr 2023 to Apr 2024